Metastatic Triple Negative Breast Cancer

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB125527-ethyl-10-hydroxycamptothecin1Completed1
DB11595Atezolizumab1Active Not Recruiting1
DB00958Carboplatin1Completed1
DB13896Talimogene laherparepvec1Active Not Recruiting1
DB00945Acetylsalicylic acid1 / 2Recruiting1
DB00381Amlodipine1 / 2Recruiting1
DB01248Docetaxel1 / 2Recruiting1
DB01097Leflunomide1 / 2Recruiting1
DB01229Paclitaxel1 / 2Completed1
DB00019Pegfilgrastim1 / 2Recruiting1
DB11815Tilarginine1 / 2Recruiting1
DB00112Bevacizumab2Recruiting1
DB00958Carboplatin2Completed1
DB14917Ceralasertib2Recruiting1
DB00825Levomenthol2Recruiting1
DB09074Olaparib2Recruiting1
DB01229Paclitaxel2Completed1
DB09037Pembrolizumab2Completed1
DB08937TAS-1022Withdrawn1
DB09343Tipiracil2Withdrawn1
DB00432Trifluridine2Withdrawn1
DB01128Bicalutamide3Recruiting1
DB01101Capecitabine3Active Not Recruiting1
DB08871Eribulin3Active Not Recruiting1
DB00441Gemcitabine3Active Not Recruiting1
DB09037Pembrolizumab3Active Not Recruiting1
DB00361Vinorelbine3Active Not Recruiting1
DB01259LapatinibNot AvailableActive Not Recruiting1
DB07232VeliparibNot AvailableActive Not Recruiting1